Home LiteratureArticle Details
PMID: 21788578 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The metabolically benign and malignant fatty liver.

Diabetes ·Vol. 60 ·No. 8 ·2011-08-00 ·Pages 2011-7

Stefan N, Häring HU

Abstract

暂无摘要

MeSH Terms
Animals Cardiovascular Diseases/etiology Child Diabetes Mellitus, Type 1/etiology Fatty Liver/epidemiology,etiology,metabolism Hepatitis/metabolism Humans Insulin Resistance/physiology Lipase/physiology Liver Neoplasms Membrane Proteins/physiology Non-alcoholic Fatty Liver Disease Obesity/complications Risk Factors Triglycerides/metabolism
Chemicals
Membrane Proteins Triglycerides Lipase adiponutrin, human
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Stefan Norbert
Department of Internal Medicine IV, Division of Endocrinology, Diabetology, Vascular Medicine, Nephrology and Clinical Chemistry, University of Tübingen, Tübingen, Germany. [email protected]
Häring Hans-Ulrich
References (53)
53 references, click to expand
  1. Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.
    Diabetes Care. 2006 Apr;29(4):853-7 PMID: 16567827
  2. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB.
    Nat Med. 2005 Feb;11(2):183-90 PMID: 15685173
  3. Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria.
    J Biol Chem. 2009 May 29;284(22):14809-18 PMID: 19332540
  4. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice.
    Gastroenterology. 2010 Jul;139(1):323-34.e7 PMID: 20347818
  5. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke.
    Circulation. 2008 Dec 9;118(24):2555-62 PMID: 19029462
  6. Interleukin-6 signaling in liver-parenchymal cells suppresses hepatic inflammation and improves systemic insulin action.
    Cell Metab. 2010 Sep 8;12(3):237-49 PMID: 20816090
  7. Prevention of steatosis by hepatic JNK1.
    Cell Metab. 2009 Dec;10(6):491-8 PMID: 19945406
  8. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
    Liver Int. 2011 Mar;31(3):412-6 PMID: 21281435
  9. Lipid-induced insulin resistance: unravelling the mechanism.
    Lancet. 2010 Jun 26;375(9733):2267-77 PMID: 20609972
  10. Association of AHSG gene polymorphisms with fetuin-A plasma levels and cardiovascular diseases in the EPIC-Potsdam study.
    Circ Cardiovasc Genet. 2009 Dec;2(6):607-13 PMID: 20031641
  11. PNPLA3 variants specifically confer increased risk for histologic nonalcoholic fatty liver disease but not metabolic disease.
    Hepatology. 2010 Sep;52(3):904-12 PMID: 20648472
  12. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
    J Biol Chem. 2009 Feb 27;284(9):5637-44 PMID: 19119140
  13. Identification and characterization of metabolically benign obesity in humans.
    Arch Intern Med. 2008 Aug 11;168(15):1609-16 PMID: 18695074
  14. Triglyceride accumulation protects against fatty acid-induced lipotoxicity.
    Proc Natl Acad Sci U S A. 2003 Mar 18;100(6):3077-82 PMID: 12629214
  15. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance.
    Science. 2008 Dec 5;322(5907):1539-43 PMID: 19056984
  16. Plasma fetuin-A levels and the risk of type 2 diabetes.
    Diabetes. 2008 Oct;57(10):2762-7 PMID: 18633113
  17. Crucial role of a long-chain fatty acid elongase, Elovl6, in obesity-induced insulin resistance.
    Nat Med. 2007 Oct;13(10):1193-202 PMID: 17906635
  18. Mechanisms of Disease: hepatic steatosis in type 2 diabetes--pathogenesis and clinical relevance.
    Nat Clin Pract Endocrinol Metab. 2006 Jun;2(6):335-48 PMID: 16932311
  19. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet.
    Hepatology. 2007 Nov;46(5):1392-403 PMID: 17929294
  20. Nonalcoholic fatty liver disease.
    N Engl J Med. 2002 Apr 18;346(16):1221-31 PMID: 11961152
  21. Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance.
    Diabetes. 2010 Feb;59(2):347-57 PMID: 19934001
  22. Abdominal obesity and metabolic syndrome.
    Nature. 2006 Dec 14;444(7121):881-7 PMID: 17167477
  23. Review: The role of insulin resistance in nonalcoholic fatty liver disease.
    J Clin Endocrinol Metab. 2006 Dec;91(12):4753-61 PMID: 16968800
  24. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase.
    Science. 2006 May 5;312(5774):734-7 PMID: 16675698
  25. Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine.
    Clin Sci (Lond). 2011 Aug;121(4):179-89 PMID: 21446920
  26. NF-kappaB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance.
    Biochem J. 2010 Aug 1;429(3):451-62 PMID: 20482516
  27. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.
    Hepatology. 2010 Feb;51(2):511-22 PMID: 20054868
  28. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance.
    Diabetes. 2008 Aug;57(8):2037-45 PMID: 18487449
  29. Mechanisms of disease progression in nonalcoholic fatty liver disease.
    Semin Liver Dis. 2008 Nov;28(4):370-9 PMID: 18956293
  30. A feed-forward loop amplifies nutritional regulation of PNPLA3.
    Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7892-7 PMID: 20385813
  31. JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity.
    Cell Metab. 2007 Nov;6(5):386-97 PMID: 17983584
  32. Nonalcoholic fatty liver disease: Cytokine-adipokine interplay and regulation of insulin resistance.
    Gastroenterology. 2006 Sep;131(3):934-45 PMID: 16952562
  33. Fetuin-A induces cytokine expression and suppresses adiponectin production.
    PLoS One. 2008 Mar 12;3(3):e1765 PMID: 18335040
  34. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans.
    Clin Sci (Lond). 2009 Mar;116(6):531-7 PMID: 18980578
  35. Characterization of a natural inhibitor of the insulin receptor tyrosine kinase: cDNA cloning, purification, and anti-mitogenic activity.
    Cell. 1989 Aug 25;58(4):631-40 PMID: 2766355
  36. Macrophages, inflammation, and insulin resistance.
    Annu Rev Physiol. 2010;72:219-46 PMID: 20148674
  37. Influence of weight loss and physical activity interventions upon muscle lipid content in relation to insulin resistance.
    Curr Diab Rep. 2004 Jun;4(3):165-8 PMID: 15132879
  38. Sex hormone-binding globulin and risk of type 2 diabetes.
    N Engl J Med. 2009 Dec 31;361(27):2675-6; author reply 2677-8 PMID: 20042761
  39. Sex hormone-binding globulin and risk of type 2 diabetes in women and men.
    N Engl J Med. 2009 Sep 17;361(12):1152-63 PMID: 19657112
  40. Hepatic NF-kappa B essential modulator deficiency prevents obesity-induced insulin resistance but synergizes with high-fat feeding in tumorigenesis.
    Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1297-302 PMID: 18216263
  41. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children.
    Diabetologia. 2011 Apr;54(4):869-75 PMID: 21181394
  42. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease.
    Nat Genet. 2008 Dec;40(12):1461-5 PMID: 18820647
  43. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
    Cell Metab. 2007 Jul;6(1):69-78 PMID: 17618857
  44. Reactive oxygen species have a causal role in multiple forms of insulin resistance.
    Nature. 2006 Apr 13;440(7086):944-8 PMID: 16612386
  45. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene.
    Diabetes. 2009 Nov;58(11):2616-23 PMID: 19651814
  46. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
    Arterioscler Thromb Vasc Biol. 2003 Jul 1;23(7):1262-8 PMID: 12750120
  47. A liver-derived secretory protein, selenoprotein P, causes insulin resistance.
    Cell Metab. 2010 Nov 3;12(5):483-95 PMID: 21035759
  48. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.
    Gastroenterology. 2010 Jul;139(1):149-53 PMID: 20303351
  49. IKK-beta links inflammation to obesity-induced insulin resistance.
    Nat Med. 2005 Feb;11(2):191-8 PMID: 15685170
  50. Determinants of intramyocellular triglyceride turnover: implications for insulin sensitivity.
    Am J Physiol Endocrinol Metab. 2008 Feb;294(2):E203-13 PMID: 18003718
  51. Kupffer cell activation is a causal factor for hepatic insulin resistance.
    Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G107-16 PMID: 19875703
  52. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity.
    Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15430-5 PMID: 19706383
  53. Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.
    Cell Metab. 2009 Nov;10(5):419-29 PMID: 19883619
Article Info
Journal
Diabetes
Abbr.
Diabetes
ISSN
1939-327X
DOI
10.2337/db11-0231
Email
[email protected]
Published
2011-08-00
Pages
2011-7
Language
English
Region
United States
NLM ID
0372763
PMCID
PMC3142070
Subset
IM
External Links
PubMed source DOI: 10.2337/db11-0231 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2